EDAP TMS SA Financial Results Announcement
EDAP TMS SA, known for its groundbreaking work in robotic energy-based therapies, is gearing up to share its financial performance for the first quarter of 2025. Set for release before market opening, stakeholders will get a comprehensive look at the company's achievements.
Key Conference Call Details
On the day of the announcement, the Company will host a conference call and webcast that aims to provide investors and analysts with insights directly from the executive team. On this call, key figures including Ryan Rhodes, the Chief Executive Officer, Ken Mobeck, the Chief Financial Officer, and François Dietsch, the Chief Accounting Officer, will present and answer queries.
When and How to Participate
Mark your calendars for this important financial update. The call is scheduled as follows:
- Date: Thursday
- Time: 8:30 am EDT
- Domestic Dial-In: 1-800-267-6316
- International Dial-In: 1-203-518-9783
- Passcode: EDAP
Participants can also access the conference through the provided webcast link, allowing for a more engaging experience.
Exploring EDAP TMS SA
EDAP TMS SA is recognized as a leader in the field of robotic energy-based therapies. Its innovative approaches revolve around the development and distribution of minimally invasive medical devices, greatly enhanced by advanced ultrasound technology. The flagship product, Focal One®, represents a cutting-edge therapy predominantly used for prostate conditions, but its capabilities are set to extend into additional medical applications.
Innovation in Focus
The Company’s commitment to merging the latest imaging technologies with precise energy delivery systems has positioned EDAP TMS as a pioneer in enhancing patient care. As they continue to build upon their success, the financial results will undoubtedly reflect their forward momentum in robotic therapies.
Investor Relations and Company Contact Points
For stakeholders seeking further information on EDAP TMS or specific inquiries related to the upcoming announcements, the Company has designated contacts to provide assistance:
- Investor Relations: Blandine Confort
EDAP TMS SA
Phone: +33 4 72 15 31 50
Email: bconfort@edap-tms.com - Additional Investor Contact: John Fraunces
LifeSci Advisors, LLC
Phone: (917) 355-2395
Email: jfraunces@lifesciadvisors.com
Potential investors and those seeking collaboration can leverage these channels to stay informed and engaged with the essential developments of EDAP TMS SA.
Frequently Asked Questions
What is the date for EDAP TMS SA's financial results announcement?
The financial results will be announced on Thursday, May 15.
How can I participate in the conference call?
You can join the conference call by dialing the domestic or international numbers provided or by accessing the webcast link.
Who will be speaking on the conference call?
The call will feature Ryan Rhodes, CEO, Ken Mobeck, CFO, and François Dietsch, Chief Accounting Officer.
What is the focus of EDAP TMS SA?
EDAP TMS specializes in robotic energy-based therapies, focusing on minimally invasive medical devices.
How can I get investor relations information?
You can contact Blandine Confort at EDAP TMS for investor relations inquiries at +33 4 72 15 31 50 or via email.
